Hohl Benjamin bought ELVN
June 27, 2025 · Form 4 insider transaction
Hohl Benjamin bought 3,250 shares of Enliven Therapeutics, Inc. at $2.48 per share, a transaction worth $8.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,250
Price
$2.48
Total value
$8.1K
InsiderHohl Benjamin
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 27, 2025
Filing dateJuly 1, 2025
Shares owned after26,250
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.